Circulation-cardiovascular Interventions
Papers 2093
1 page of 210 pages (2,093 results)
#1Matthias Aurich (Heidelberg University)H-Index: 8
#2Martin J. Volz (Heidelberg University)H-Index: 1
Last. Philip Raake (Heidelberg University)H-Index: 25
view all 7 authors...
Background null Percutaneous tricuspid valve leaflet repair is an emerging treatment option for severe tricuspid regurgitation (TR). Recent studies demonstrated the usefulness and feasibility of the lately introduced TriClip and PASCAL Transcatheter Valve Repair System. However, initial experiences regarding safety and efficacy of the novel transcatheter PASCAL Ace implant system have not yet been reported. null Methods null Sixteen patients with severe, massive, or torrential TR underwent tricu...
#1Tamim Nazif (NewYork–Presbyterian Hospital)H-Index: 31
#2Thomas Cahill (NewYork–Presbyterian Hospital)H-Index: 1
Last. Bassem M. ChehabH-Index: 6
view all 17 authors...
Background: Paravalvular regurgitation (PVR) after transcatheter aortic valve replacement is associated with adverse clinical outcomes. The SAPIEN 3 Ultra (Ultra) is a new generation balloon-expand...
#1Pierre Denormandie (University of Paris)
#2Tabassome Simon (UPMC: Pierre-and-Marie-Curie University)H-Index: 60
Last. Francois Schiele (University of Burgundy)H-Index: 51
view all 21 authors...
Background: In patients with ST-elevation myocardial infarction (STEMI) and multivessel disease, percutaneous coronary intervention (PCI) for non-culprit lesions guided by FFR is superior to treatm...
#1Giulio Russo (UCSC: Catholic University of the Sacred Heart)H-Index: 1
#2Marco Gennari (UZH: University of Zurich)H-Index: 1
Last. Francesco MaisanoH-Index: 84
view all 7 authors...
Mitral transcatheter therapies represent the treatment of choice for all patients deemed unsuitable for cardiac surgery. So far, the largest clinical experience has been limited to percutaneous repair techniques. However, given the complexity and heterogeneity of mitral valve anatomy and pathology, transcatheter mitral valve implantation will widen the mitral valve therapies horizon, toward a patient-tailored approach. Current data about transcatheter mitral valve implantation is still limited a...
BACKGROUND Percutaneous mitral valve repair (PMVR) in high-risk patients is currently controversial, especially in those with secondary mitral regurgitation (MR). Exercise pulmonary hemodynamics may help to unmask cardiac dysfunction as well as the dynamic impact of MR. The present study sought to explore the clinical impact of preprocedural exercise right heart catheterization (RHC) for the selection of patients who could most benefit from PMVR. METHODS Sixty-eight patients with symptomatic pri...
#1Dean J. KereiakesH-Index: 108
#2Robert L. FeldmanH-Index: 56
Last. John M. Lasala (WashU: Washington University in St. Louis)H-Index: 29
view all 14 authors...
Background null The SVELTE fixed-wire and rapid exchange bioresorbable-polymer sirolimus-eluting coronary stent systems (SVELTE sirolimus-eluting stent [SES]) are novel, low-profile devices designed to facilitate direct stenting, transradial access, and enhance procedural efficiencies. null Methods null Eligible subjects (N=1639) scheduled to undergo percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction or stable coronary artery disease were randomly assigned (1:1...
1 CitationsSource
#1Natalia Briceno (NIHR: National Institute for Health Research)H-Index: 6
#2Matthew Ryan (NIHR: National Institute for Health Research)H-Index: 8
Last. Divaka Perera (NIHR: National Institute for Health Research)H-Index: 26
view all 10 authors...
#1Eric A. Secemsky (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 19
#2Neel M. Butala (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 10
Last. Kendrick A. Shunk (Veterans Health Administration)H-Index: 27
view all 13 authors...
Background null Prior studies on the use of multivessel percutaneous coronary intervention (MV PCI) for patients with ST-segment-elevation myocardial infarction (STEMI) and multivessel coronary artery disease have yielded heterogeneous results. The recent COMPLETE trial (Complete Versus Culprit-Only Revascularization Strategies to Treat Multivessel Disease After Early PCI for STEMI) demonstrated that MV PCI was superior to culprit-only PCI among patients with STEMI. It is unclear how these trial...
#1Andrew M. Goldsweig (UNMC: University of Nebraska Medical Center)H-Index: 12
#2Vladimír Džavík (UHN: University Health Network)H-Index: 25
Last. Vladimír Džavík (UNMC: University of Nebraska Medical Center)
view all 2 authors...
#1Christopher Rajkumar (NIH: National Institutes of Health)H-Index: 7
#2Matthew J. Shun-Shin (NIH: National Institutes of Health)H-Index: 24
Last. Caitlin Khan (NIH: National Institutes of Health)
view all 32 authors...
Background null Physiological assessment with pressure wire pullback can characterize coronary artery disease (CAD) with a focal or diffuse pattern. However, the clinical relevance of this distinction is unknown. We use data from the ORBITA trial (Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina) to test if the pattern of CAD predicts the placebo-controlled efficacy of percutaneous coronary intervention (PCI) on stress echocardiography ische...
1 CitationsSource
Top fields of study
Percutaneous coronary intervention
Myocardial infarction